Navigation Links
STAAR Surgical Collamer(R) Accommodating Study Team Reports First Phase Assessments at AAO
Date:10/26/2009

ng Collamer are protected by patents. Lenses made of Collamer have been approved by the FDA for implantation since 2000. More information is available at www.staar.com.

Safe Harbor

All statements in this press release that are not statements of historical fact are forward-looking statements, including statements about any of the following: projections of any financial items; the plans, strategies, and objectives of management for future operations or prospects for achieving such plans; our future performance; statements of belief; and any statements of assumptions underlying any of the foregoing.

STAAR's current data on the accommodating properties of the Collamer material derive from the reports of individual independent clinicians and have not been subjected to large scale clinical studies. STAAR's current nanoFLEX IOL does not currently have an FDA labeling claim for accommodation. STAAR cannot assure that its further research will support a claim that either its current Collamer lenses or future designs restore the eye's ability to accommodate. If clinical research does not support these claims, or supports only a narrow range of accommodation, STAAR's Collamer accommodation project may not result in increased sales. New lens designs may require clinical research studies and applying for the FDA's premarket approval, which are expensive and could result in delay or denial of approval. Other risks and uncertainties include our limited capital resources and limited access to financing, the fact that our public accounting firm has expressed doubt about our ability to continue as a going concern in their opinion on our financial statements, the cost of defending pending litigation and satisfying judgment in the event of an adverse ruling, for which we have taken no reserve, the negative effect of the global recession on sales of products, especially
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. STAAR Surgical Reports Operational Progress
2. STAAR Surgical Announces Third Quarter 2007 Earnings Release Date and Conference Call
3. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
4. STAAR Surgical Reports Third Quarter Results
5. Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical
6. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
7. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
8. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
9. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
10. STAAR Surgicals Visian ICL Procedure Performed Live on NBCs Today show
11. STAAR Surgical Reports Fourth Quarter and Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 01, 2015 GrassrootsHealth, an international ... continuing medical education (CME) courses about vitamin ... become more confident in measuring, prescribing, and tracking ... of these CME courses, practitioners can apply for ... courses available are “Vitamin D, Sunshine, Optimal Health: ...
(Date:4/1/2015)... 2015 Tempaper has joined forces with ... giving campaign that will raise critical funds to help ... disease across the United States. , Throughout the month ... Tempaperdesigns.com will automatically receive free domestic ground shipping ... urgently needed progress to children and adults affected by ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Like a ... is the scientific understanding of the potential causes of ... by the National Rosacea Society (NRS) to educate the ... treatable facial disorder now estimated to affect more than ... supported medical research on rosacea through its patient-funded research ...
(Date:4/1/2015)... IQ Formulations , one of the ... companies in the U.S., today is commending GNC for taking ... standards for its herbal supplements.* GNC vowed that its new ... the accuracy of labeling on its products. , In ... Formulations CEO Jay Cohen said: , “In a ...
(Date:4/1/2015)... MEETING, PA (PRWEB) April 01, 2015 ... assistance company and a subsidiary of West Corporation, today ... available at http://blog.healthadvocate.com and through the Health ... help healthcare consumers get, and stay, healthy. , “We’re ... contents available to the public,” said Martin Rosen, Executive ...
Breaking Medicine News(10 mins):Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Health Advocate Launches New Health and Wellness Blog 2
... there are actually scientific reasons why children may be ... strong // sweet tooth. Researchers found variation in a ... and adults. Age and culture also contribute to taste ... the study researchers compared taste sensitivity and food-related behaviors ...
... that looked at how in utero exposures affect the ... babies // have a higher risk of developing certain ... larger birth weight and increased rates of adult cancer ... to examine this hypothesis. Thus they set out to ...
... to 20,000 new HIV infections each year can be ... // status. Early identification of HIV is critical. Without ... damage. ,Two new studies show screening for ... for many patients. Researchers reported expanded HIV screening may ...
... Chennai today. The theme for the congress is Prevention of ... will attend the event from 38 countries across the world. ... once in every three years, since the time of its ... of the city is hosting this year’s three-day event ...
... Newborns deprived of oxygen can have a reduced risk of ... // for 72 hours after birth according to a recent ... oxygen to the brain during delivery showed signs of being ... brain damage does not happen immediately when babies are oxygen-deprived ...
... evaluation tool can predict the mortality risk in patients hospitalized ... a recent study. According to researchers the new bedside tool ... acute heart failure and offers a simple, quick way for ... decide on a treatment strategy. ,Researchers used data from ...
Cached Medicine News:
(Date:4/1/2015)... 1, 2015  Philips Respironics, a division of Royal ... the Pico nasal mask is now available in ... of obstructive sleep apnea (OSA). Designed to maximize comfort and ... air pressure (CPAP) mask available on the market to treat ... solutions, will be on display at Medtrade Spring ...
(Date:4/1/2015)... MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology company ... announced today that Daniel P. Gold , Ph.D., President ... Annual Needham Healthcare Conference on Wednesday, April 15, 2015 ... Hotel in New York . A live ... . A replay will be available approximately one hour after ...
(Date:4/1/2015)... 1, 2015  Salix Pharmaceuticals, Ltd. ("Salix"), a ... (NYSE: VRX ) (TSX:VRX), today announced that ... aggregate principal amount of its 6.00% Senior Notes ... Notes ") pursuant to two redemptions. On May ... amount of the Notes, and on May 4, ...
Breaking Medicine Technology:Philips Pico CPAP Nasal Mask Now Available in the United States 2Philips Pico CPAP Nasal Mask Now Available in the United States 3MEI Pharma to Present at Needham Healthcare Conference 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3
... 17 Dynatronics Corporation (Nasdaq: DYNT ) today announced ... for the last 30 consecutive business days, the bid price of ... per share requirement for continued inclusion under NASDAQ,s Marketplace Rules. As ... until December 13, 2010 , to regain compliance. If, at ...
... CONSHOHOCKEN, Pa. , June 17 ePharmaSolutions, a leading ... 3.0 of its eMVR (Electronic Monitor Visit Report) application with new ... traveling clinical research associates and integrations with leading CTMS systems. , ... "Our latest release ...
Cached Medicine Technology:Dynatronics Receives NASDAQ Minimum Bid Price Deficiency Letter 2Dynatronics Receives NASDAQ Minimum Bid Price Deficiency Letter 3ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: